Results 161 to 170 of about 336,084 (346)

18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma. [PDF]

Clin Nucl Med, 2021
Jadvar H, In GK.
europepmc   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

A case of metastatic basal cell carcinoma treated with carboplatin and paclitaxel

Dermatology Practical & Conceptual, 2023
Chryssoula Papageorgiou, Zoe Apalla, Eleni Timotheadou, Konstantia Loga, Elizabeth Lazaridou, Dimitrios Dionysopoulos   +5 more
doaj   +1 more source

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study [PDF]

, 2013
Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, Lauren C. Harshman, Georg A. Bjarnason, Ulka N. Vaishampayan, Mary J. MacKenzie, Lori Wood, Frede Donskov, Min-Han Tan, Sun Young Rha, Neeraj Agarwal, Christian Kollmannsberger, Brian I. Rini, Toni K. Choueiri   +14 more
openalex   +1 more source

428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs) [PDF]

, 2020
Karl D. Lewis, Ketty Peris, Aleksandar Sekulić, Alexander Stratigos, Lara Dunn, Zeynep Eroglu, Anne Lynn S. Chang, Michael R. Migden, Siyu Li, Kosalai Kal Mohan, Ebony Coates, Emmanuel Chiebuka Okoye, Jean‐François Baurain, Oliver Bechter, Axel Hauschild, Marcus O. Butler, Leonel F. Hernandez‐Aya, Lisa Licitra, Rogerio I. Neves, E.P. Yanez Ruiz, Frank Seebach, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Timothy G. Bowler, Matthew G. Fury   +25 more
openalex   +1 more source

Selection of Optimal Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Clear Cell Renal Cell Carcinoma: A Predictive Model Based on SEER Database [PDF]

, 2022
Yishan Zhang, Jintao Hu, Jingtian Yang, Yingwei Xie, Zhiliang Chen, Wentai Shangguan, Jinli Han, He Wang, Jingyin Yang, Zaosong Zheng, Qiyu Zhong, Dingjun Zhu, Wenlian Xie   +12 more
openalex   +1 more source

RKIP overexpression reduces lung adenocarcinoma aggressiveness and sensitizes cells to EGFR‐targeted therapies

Molecular Oncology, EarlyView.
RKIP, a metastasis suppressor protein, modulates key oncogenic pathways in lung adenocarcinoma. In silico analyses linked low RKIP expression to poor survival. Functional studies revealed RKIP overexpression reduces tumor aggressiveness and enhances sensitivity to EGFR‐targeted therapies, while its loss promotes resistance.
Ana Raquel‐Cunha, Joana Pinheiro, Rui F. Marques, Patrícia Fontão, Diana Cardoso‐Carneiro, Adriana Mendes, Izabela N. F. Gomes, Ana Carolina Laus, Renato J. da Silva‐Oliveira, Rui Manuel Reis, Olga Martinho   +10 more
wiley   +1 more source

701O Assessment of circulating cell-free tumor DNA (ctDNA) in 847 patients (pts) with metastatic renal cell carcinoma (mRCC) and concordance with tissue-based testing [PDF]

, 2020
Zeynep Büşra Zengin, Caroline Weipert, Joann Hsu, Nicholas Salgia, Jennifer Saam, Toni K. Choueiri, Neeraj Agarwal, Sumanta K. Pal   +7 more
openalex   +1 more source

Development and validation of a prognostic nomogram for predicting cancer-specific survival in patients with metastatic clear cell renal carcinoma: A study based on SEER database [PDF]

, 2022
Guangyi Huang, Jie Liao, Songwang Cai, Zheng Chen, Xiaoping Qin, Longhong Ba, Jingmin Rao, Weimin Zhong, Ying Lin, Yuying Liang, Liwei Wei, Jinhua Li, Kaifeng Deng, Xiangyue Li, Zexiong Guo, Liang Wang, Yumin Zhuo   +16 more
openalex   +1 more source

Single‐cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology

Molecular Oncology, EarlyView.
Single‐cell transcriptomics of prostate cancer patient‐derived xenografts reveals distinct features of neuroendocrine (NE) subtypes. Tumours with focal NE differentiation (NED) share transcriptional programmes with adenocarcinoma, differing from large and small cell neuroendocrine prostate cancer (NEPC). Our work defines the molecular landscape of NEPC,
Rosalia Quezada Urban, Shivakumar Keerthikumar, Ashlee Clark, Hong Wang, Belinda Phipson, Andrew Bakshi, Andrew Ryan, Heather Thorne, Renea A. Taylor, Mitchell G. Lawrence, Gail P. Risbridger, Roxanne Toivanen, David L. Goode   +12 more
wiley   +1 more source